As we wait for the EMA’s decision, a top Norwegian health official tasked with investigating a series of three high-profile cases of health-care workers under the age of 50 being hospitalized for similar cases of rare blood clots after receiving the AstraZeneca vaccine have proposed a theory that’s bound to infuriate AstraZeneca, along with the EMA and WHO.
Chief physician and professor Pål Andre Holme told Norwegian papers on Thursday, just hours before the EMA was set to release the findings of its promised “safety review” (which was conducted even more hastily than the initial vaccine studies), that he has a new theory about what caused the reactions in the health workers, and unfortunately, per Holme, the AstraZeneca jab acted as the trigger.
“The reason for the condition of our patients has been found,” chief physician and professor Pål Andre Holme announced to Norwegian national newspaper VG today.
He has lead the work to find out why three health workers under the age of 50 were hospitalized with serious blood clots and low levels of blood platelets after having taken the AstraZeneca Covid vaccine. One of the health workers died on Monday.
The experts have worked on a theory that it was in fact the vaccine which triggered and unexpected and powerful immune response – a theory they now believe they have confirmed.
“Our theory that this is a powerful immune response which most likely was caused by the vaccine has been found. In collaboration with experts in the field from the University Hospital of North Norway HF, we have found specific antibodies against blood platelets that can cause these reactions, and which we know from other fields of medicine, but then with medical drugs as the cause of the reaction,” the chief physician explains to VG.
Though he acknowledged the theory was just that – a theory, Holme insisted there was nothing else that could have triggered such an intense immune response in all three patients. The vaccine was the only common factor. – READ MORE
Listen to the insightful Thomas Paine Podcast Below --